vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and PJT Partners Inc. (PJT). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $531.4M, roughly 1.8× PJT Partners Inc.). PJT Partners Inc. runs the higher net margin — 10.0% vs 7.7%, a 2.3% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 12.9%). PJT Partners Inc. produced more free cash flow last quarter ($138.6M vs $96.9M). Over the past eight quarters, PJT Partners Inc.'s revenue compounded faster (27.5% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
ATR vs PJT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $531.4M |
| Net Profit | $74.3M | $53.4M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 23.1% |
| Net Margin | 7.7% | 10.0% |
| Revenue YoY | 13.5% | 12.9% |
| Net Profit YoY | -26.4% | 4.0% |
| EPS (diluted) | $1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $531.4M | ||
| Q3 25 | $961.1M | $442.3M | ||
| Q2 25 | $966.0M | $401.1M | ||
| Q1 25 | $887.3M | $321.9M | ||
| Q4 24 | $848.1M | $470.5M | ||
| Q3 24 | $909.3M | $320.3M | ||
| Q2 24 | $910.1M | $358.1M | ||
| Q1 24 | $915.4M | $327.1M |
| Q4 25 | $74.3M | $53.4M | ||
| Q3 25 | $127.9M | $39.8M | ||
| Q2 25 | $111.7M | $32.9M | ||
| Q1 25 | $78.8M | $54.0M | ||
| Q4 24 | $100.9M | $51.3M | ||
| Q3 24 | $100.0M | $22.1M | ||
| Q2 24 | $90.5M | $28.3M | ||
| Q1 24 | $83.1M | $32.6M |
| Q4 25 | 11.0% | 23.1% | ||
| Q3 25 | 14.2% | 20.6% | ||
| Q2 25 | 14.9% | 19.1% | ||
| Q1 25 | 12.8% | 16.3% | ||
| Q4 24 | 14.2% | 21.9% | ||
| Q3 24 | 15.2% | 15.4% | ||
| Q2 24 | 13.8% | 18.0% | ||
| Q1 24 | 12.2% | 16.5% |
| Q4 25 | 7.7% | 10.0% | ||
| Q3 25 | 13.3% | 9.0% | ||
| Q2 25 | 11.6% | 8.2% | ||
| Q1 25 | 8.9% | 16.8% | ||
| Q4 24 | 11.9% | 10.9% | ||
| Q3 24 | 11.0% | 6.9% | ||
| Q2 24 | 9.9% | 7.9% | ||
| Q1 24 | 9.1% | 10.0% |
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — | ||
| Q1 24 | $1.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $538.9M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $308.2M |
| Total Assets | $5.3B | $1.8B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $538.9M | ||
| Q3 25 | $264.8M | $400.5M | ||
| Q2 25 | $169.8M | $214.6M | ||
| Q1 25 | $136.8M | $194.3M | ||
| Q4 24 | $226.2M | $483.9M | ||
| Q3 24 | $327.9M | $148.8M | ||
| Q2 24 | $223.9M | $164.2M | ||
| Q1 24 | $201.1M | $215.5M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $308.2M | ||
| Q3 25 | $2.8B | $228.6M | ||
| Q2 25 | $2.7B | $167.4M | ||
| Q1 25 | $2.5B | $148.8M | ||
| Q4 24 | $2.5B | $187.0M | ||
| Q3 24 | $2.5B | $159.1M | ||
| Q2 24 | $2.4B | $133.8M | ||
| Q1 24 | $2.3B | $174.6M |
| Q4 25 | $5.3B | $1.8B | ||
| Q3 25 | $5.1B | $1.7B | ||
| Q2 25 | $4.9B | $1.5B | ||
| Q1 25 | $4.5B | $1.4B | ||
| Q4 24 | $4.4B | $1.6B | ||
| Q3 24 | $4.6B | $1.6B | ||
| Q2 24 | $4.5B | $1.4B | ||
| Q1 24 | $4.4B | $1.3B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $155.7M |
| Free Cash FlowOCF − Capex | $96.9M | $138.6M |
| FCF MarginFCF / Revenue | 10.1% | 26.1% |
| Capex IntensityCapex / Revenue | 9.0% | 3.2% |
| Cash ConversionOCF / Net Profit | 2.47× | 2.92× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $480.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $155.7M | ||
| Q3 25 | $177.6M | $256.1M | ||
| Q2 25 | $126.0M | $190.4M | ||
| Q1 25 | $82.7M | $-75.9M | ||
| Q4 24 | $178.2M | $195.7M | ||
| Q3 24 | $229.3M | $180.5M | ||
| Q2 24 | $143.6M | $193.6M | ||
| Q1 24 | $92.3M | $-38.8M |
| Q4 25 | $96.9M | $138.6M | ||
| Q3 25 | $114.3M | $240.9M | ||
| Q2 25 | $62.5M | $178.9M | ||
| Q1 25 | $25.9M | $-77.9M | ||
| Q4 24 | $112.2M | $195.3M | ||
| Q3 24 | $162.7M | $178.5M | ||
| Q2 24 | $75.4M | $193.0M | ||
| Q1 24 | $16.7M | $-39.2M |
| Q4 25 | 10.1% | 26.1% | ||
| Q3 25 | 11.9% | 54.5% | ||
| Q2 25 | 6.5% | 44.6% | ||
| Q1 25 | 2.9% | -24.2% | ||
| Q4 24 | 13.2% | 41.5% | ||
| Q3 24 | 17.9% | 55.7% | ||
| Q2 24 | 8.3% | 53.9% | ||
| Q1 24 | 1.8% | -12.0% |
| Q4 25 | 9.0% | 3.2% | ||
| Q3 25 | 6.6% | 3.4% | ||
| Q2 25 | 6.6% | 2.9% | ||
| Q1 25 | 6.4% | 0.6% | ||
| Q4 24 | 7.8% | 0.1% | ||
| Q3 24 | 7.3% | 0.6% | ||
| Q2 24 | 7.5% | 0.1% | ||
| Q1 24 | 8.3% | 0.1% |
| Q4 25 | 2.47× | 2.92× | ||
| Q3 25 | 1.39× | 6.43× | ||
| Q2 25 | 1.13× | 5.79× | ||
| Q1 25 | 1.05× | -1.41× | ||
| Q4 24 | 1.77× | 3.81× | ||
| Q3 24 | 2.29× | 8.15× | ||
| Q2 24 | 1.59× | 6.84× | ||
| Q1 24 | 1.11× | -1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
PJT
Segment breakdown not available.
